IP Library Granted Patent US 9,644,204
Granted Patent B2
US 9,644,204 · App. 14/175,935 · Granted May 9, 2017

Partitioning and processing of analytes and other species

Inventors: Benjamin Hindson (Pleasanton, CA); Serge Saxonov (Oakland, CA); Kevin Ness (Pleasanton, CA); Paul Hardenbol (San Francisco, CA); Christopher Hindson (Pleasanton, CA); Donald Masquelier (Tracy, CA); Mirna Jarosz (Palo Alto, CA); Michael Schnall-Levin (Palo Alto, CA)
Assignee: 10X GENOMICS, INC.
C12N15/1065C12N15/11C12Q1/6806C12Q1/6874C12Q1/6876G01N33/5436C12Q2600/112
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,644,204
App. No.
14/175,935
Filed
Feb 7, 2014
Granted
May 9, 2017
Kind
B2
Art Unit
1634
USPC
435/6.1
Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

Claims (44)

1. A composition comprising a plurality of capsules, said capsules situated within droplets in an emulsion, wherein said capsules are configured to release their contents into said droplets upon the application of a stimulus to provide said contents in said droplets in said emulsion, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof.

2. The composition of claim 1 , wherein at least one of said capsules and said droplets comprise a species selected from the group consisting of a reagent and an analyte.

3. The composition of claim 2 , wherein said reagent is selected from the group consisting of a protein, a polynucleotide, an enzyme, an antibody, a barcode, an adapter, a buffer, a small molecule, a detergent, a dye, a polymer and combinations thereof.

4. The composition of claim 3 , wherein said enzyme is selected from the group consisting of a proteinase, a restriction enzyme, a ligase, a polymerase, a fragmentase, a reverse transcriptase, a transposase, and combinations thereof.

5. The composition of claim 4 , wherein said restriction enzyme is a restriction enzyme that is a rare cutter.

6. The composition of claim 3 , wherein said barcode is an oligonucleotide barcode.

7. The composition of claim 2 , wherein said analyte is selected from the group consisting of a cell, a polynucleotide, a chromosome, a protein, a peptide, a polysaccharide, a sugar, a lipid, a small molecule, and combinations thereof.

8. The composition of claim 7 , wherein said analyte is a polynucleotide.

9. The composition of claim 8 , wherein said polynucleotide is selected from the group consisting of DNA, RNA, cDNA, and combinations thereof.

10. The composition of claim 8 , wherein the amount of said polynucleotide in said composition is an amount sufficient to provide about 100-200X sequence coverage.

11. The composition of claim 7 , wherein each capsule comprises, on average, about one chromosome.

12. The composition of claim 1 , wherein each droplet comprises, on average, about 1 capsule per droplet.

13. The composition of claim 1 , wherein each droplet can hold, at most, a single capsule.

14. The composition of claim 1 , wherein at least one of said capsules comprises a further partition.

15. The composition of claim 14 , wherein said further partition is selected from the group consisting of a capsule and a droplet in an emulsion.

16. The composition of claim 1 , wherein at least one of said capsules has a shell selected from the group consisting of a polymeric shell, a hydrogel, a hydrophilic shell, a hydrophobic shell, a shell with a net positive charge, a shell with a net negative charge, a shell with a neutral charge, and combinations thereof.

17. The composition of claim 1 , wherein said droplets comprise a fluid that is of a lesser density than the density of said capsules.

18. The composition of claim 1 , wherein said droplets comprise a fluid that is of a greater density than the density of said capsules.

19. The composition of claim 1 , wherein said capsules are produced by a method selected from the group consisting of emulsification polymerization, layer-by-layer assembly with polyelectrolytes, coacervation, internal phase separation, flow focusing, and combinations thereof.

20. The composition of claim 1 , wherein said stimulus is applied to said capsules.

21. The composition of claim 1 , wherein said stimulus is applied to said droplets.

22. A composition comprising a plurality of outer capsules in an emulsion, said outer capsules comprising at least one inner capsule, wherein said at least one inner capsule is configured to release its contents into at least one outer capsule among said plurality of outer capsules upon the application of a stimulus to provide said contents in said outer capsule in said emulsion, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof.

23. A device comprising a plurality of partitions, wherein at least one partition of said plurality of partitions comprises a capsule, wherein said capsule is situated within a droplet in an emulsion, wherein said capsule is configured to release its contents into said droplet upon the application of a stimulus to provide said contents in said droplet in said emulsion, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof.

24. A device comprising a plurality of partitions, wherein at least one partition of said plurality of partitions comprises an outer capsule in an emulsion, said outer capsule comprising at least one inner capsule, wherein said at least one inner capsule is configured to release its contents into said outer capsule upon the application of a stimulus to provide said contents in said outer capsule in said emulsion, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof.

25. A method comprising:

a. providing a plurality of capsules, said capsules situated within droplets in an emulsion, wherein said capsules are configured to release their contents into said droplets upon the application of a stimulus, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof; and

b. providing a stimulus to cause said capsules to release their contents into said droplets in said emulsion.

26. A method comprising:

a. providing a plurality of inner capsules, said inner capsules situated within outer capsules in an emulsion, wherein said inner capsules are configured to release their contents into said outer capsules upon the application of a stimulus, wherein said stimulus is selected from the group consisting of a change in pH, a change in ion concentration, reduction of disulfide bonds, and combinations thereof; and

b. providing a stimulus to cause said inner capsules to release their contents into said outer capsules in said emulsion.

27. The composition of claim 1 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to each of said capsules.

28. The composition of claim 22 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to said inner capsule.

29. The device of claim 23 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to said capsule.

30. The device of claim 24 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to said inner capsule.

31. The method of claim 25 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to each of said capsule.

32. The method of claim 26 , wherein said contents comprise at least 10,000 barcoded oligonucleotides releasably attached to each of said inner capsule.

33. The composition of claim 1 , wherein said capsules are gels.

34. The composition of claim 22 , wherein said inner capsule is a gel.

35. The composition of claim 22 , wherein at least one of said inner capsules and said outer capsules comprise a species selected from the group consisting of a reagent and an analyte.

36. The composition of claim 35 , wherein said reagent is selected from the group consisting of a protein, a polynucleotide, an enzyme, an antibody, a barcode, an adaptor, a buffer, a small molecule, a detergent, a dye, a polymer and combinations thereof.

37. The composition of claim 36 , wherein said enzyme is selected from the group consisting of a proteinase, a restriction enzyme, a ligase, a polymerase, a fragmentase, a reverse transcriptase, a transposase, and combinations thereof.

38. The composition of claim 36 , wherein said barcode is an oligonucleotide barcode.

39. The composition of claim 35 , wherein said analyte is selected from the group consisting of a cell, a polynucleotide, a chromosome, a protein, a peptide, a polysaccharide, a sugar, a lipid, a small molecule, and combinations thereof.

40. The composition of claim 39 , wherein said analyte is a polynucleotide.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2018
From: HINDSON, BENJAMIN; SAXONOV, SERGE; NESS, KEVIN; HARDENBOL, PAUL; HINDSON, CHRISTOPHER; MASQUELIER, DONALD; JAROSZ, MIRNA; SCHNALL-LEVIN, MICHAEL
To: 10X TECHNOLOGIES, INC.
Reel/Frame 046877/0129 →
CHANGE OF NAME Recorded Sep 14, 2018
From: 10X TECHNOLOGIES, INC.
To: 10X GENOMICS, INC.
Reel/Frame 047529/0722 →
CHANGE OF NAME Recorded Jan 22, 2015
From: 10X TECHNOLOGIES, INC.
To: 10X GENOMICS, INC.
Reel/Frame 034795/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2014
From: HINDSON, BENJAMIN; SAXONOV, SERGE; NESS, KEVIN; HARDENBOL, PAUL; HINDSON, CHRISTOPHER; MASQUELIER, DONALD; JAROSZ, MIRNA; SCHNALL-LEVIN, MICHAEL
To: 10X TECHNOLOGIES, INC.
Reel/Frame 034454/0239 →
Continuity (5)
Provisional Application 61762435 · Feb 8, 2013
Provisional Application 61800223 · Mar 15, 2013
Provisional Application 61840403 · Jun 27, 2013
Provisional Application 61844804 · Jul 10, 2013
Related Publication 20140227684A1 · Aug 14, 2014